Pulmonary marginal zone lymphoma: A single centre experience and review of the SEER database

References

• Freeman C, Berg J W, Cutler S J. Occurrence and prognosis of extranodal lymphomas. Cancer 1972; 29: 252–260
   PubMed Web of Science ®Google Scholar
• Miller D L, Allen M S. Rare pulmonary neoplasms. Mayo Clin Proc 1993; 68: 492–498
   PubMed Web of Science ®Google Scholar
• Ahmed S, Siddiqui A K, Rai K R. Low-grade B-cell bronchial associated lymphoid tissue (BALT) lymphoma. Cancer Invest 2002; 20: 1059–1068
   PubMed Web of Science ®Google Scholar
• Cordier J F, Chailleux E, Lauque D, Reynaud-Gaubert M, Dietemann-Molard A, Dalphin J C, et al. Primary pulmonary lymphomas. A clinical study of 70 cases in nonimmunocompromised patients. Chest 1993; 103: 201–208
   PubMed Web of Science ®Google Scholar
• Ferraro P, Trastek V F, Adlakha H, Deschamps C, Allen M S, Pairolero P C. Primary non-Hodgkin's lymphoma of the lung. Ann Thorac Surg 2000; 69: 993–997
   PubMed Web of Science ®Google Scholar
• Li G, Hansmann M L, Zwingers T, Lennert K. Primary lymphomas of the lung: morphological, immunohistochemical and clinical features. Histopathology 1990; 16: 519–531
   PubMed Web of Science ®Google Scholar
• Isaacson P, Wright D H. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983; 52: 1410–1416
   PubMed Web of Science ®Google Scholar
• Thieblemont C, de la Fouchardiere A, Coiffier B. Nongastric mucosa-associated lymphoid tissue lymphomas. Clin Lymphoma 2003; 3: 212–224
   PubMedGoogle Scholar
• Zinzani P L, Magagnoli M, Galieni P, Martelli M, Poletti V, Zaja F, et al. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol 1999; 17: 1254
   PubMed Web of Science ®Google Scholar
• Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas, Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997; 8: 727–737
   PubMed Web of Science ®Google Scholar
• Zucca E, Roggero E, Bertoni F, Conconi A, Cavalli F. Primary extranodal non-Hodgkin's lymphomas, Part 2: Head and neck, central nervous system and other less common sites. Ann Oncol 1999; 10: 1023–1033
   PubMed Web of Science ®Google Scholar
• Pabst R, Gehrke I. Is the bronchus-associated lymphoid tissue (BALT) an integral structure of the lung in normal mammals, including humans?. Am J Respir Cell Mol Biol 1990; 3: 131–135
   PubMed Web of Science ®Google Scholar
• Richmond I, Pritchard G E, Ashcroft T, Avery A, Corris P A, Walters E H. Bronchus associated lymphoid tissue (BALT) in human lung: its distribution in smokers and non-smokers. Thorax 1993; 48: 1130–1134
   PubMed Web of Science ®Google Scholar
• Tschernig T, Pabst R. Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different diseases. Pathobiology 2000; 68: 1–8
   PubMed Web of Science ®Google Scholar
• Colby T V, Carrington C B. Pulmonary lymphomas: current concepts. Hum Pathol 1983; 14: 884–887
   PubMed Web of Science ®Google Scholar
• Nicholson A G, Wotherspoon A C, Diss T C, Butcher D N, Sheppard M N, Isaacson P G, et al. Pulmonary B-cell non-Hodgkin's lymphomas. The value of immunohistochemistry and gene analysis in diagnosis. Histopathology 1995; 26: 395–403
   PubMed Web of Science ®Google Scholar
• Harris N L, Jaffe E S, Diebold J, Flandrin G, Muller-Hermelink H K, Vardiman J, et al. The World Health Organisation classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 2000; 36: 69–86
   PubMedGoogle Scholar
• van Dongen J J, Langerak A W, Bruggemann M, Evans P A, Hummel M, Lavender F L, et al. Design and standardisation of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257–2317
   PubMed Web of Science ®Google Scholar
• Cheson B D, Pfistner B, Juweid M E, Gascoyne R D, Specht L, Horning S J, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25: 579–586
   PubMed Web of Science ®Google Scholar
• Kurtin P J, Myers J L, Adlakha H, Strickler J G, Lohse C, Pankratz V S, et al. Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type. Am J Surg Pathol 2001; 25: 997–1008
   PubMed Web of Science ®Google Scholar
• Zucca E, Conconi A, Pedrinis E, Cortelazzo S, Motta T, Gaspodarowicz M K, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 2003; 101: 2489–2495
   PubMed Web of Science ®Google Scholar
• Zinzani P L, Tani M, Gabriele A, Poletti V, Stefoni V, Alinari L, et al. Extranodal marginal zone B-cell lymphoma of MALT-type of the lung: single-center experience with 12 patients. Leuk Lymphoma 2003; 44: 821–824
   PubMed Web of Science ®Google Scholar
• Ahmed S, Kussick S J, Siddiqui A K, Bhuiya T A, Khan A, Sarewitz S, et al. Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease. Eur J Cancer 2004; 40: 1320–1326
   PubMed Web of Science ®Google Scholar
• Graham B B, Mathisen D J, Mark E J, Takvorian R W. Primary pulmonary lymphoma. Ann Thorac Surg 2005; 80: 1248–1253
   PubMed Web of Science ®Google Scholar
• Lee D K, Im J G, Lee K S, Lee J S, Seo J B, Goo J M, et al. B-cell lymphoma of bronchus-associated lymphoid tissue (BALT): CT features in 10 patients. J Comput Assist Tomogr 2000; 24: 30–34
   PubMed Web of Science ®Google Scholar
• Masaki Y, Sugai S. Lymphoproliferative disorders in Sjogren's syndrome. Autoimmun Rev 2004; 3: 175–182
   PubMed Web of Science ®Google Scholar
• Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Randall T D. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 2006; 116: 3183–3194
   PubMed Web of Science ®Google Scholar
• Thieblemont C, Berger F, Coiffier B. Mucosa-associated lymphoid tissue lymphomas. Curr Opin Oncol 1995; 7: 415–420
   PubMedGoogle Scholar
• Matolcsy A. High-grade transformation of low-grade non-Hodgkin's lymphomas: mechanisms of tumor progression. Leuk Lymphoma 1999; 34: 251–259
   PubMed Web of Science ®Google Scholar
• Aguilar C. Low-grade gastric MALT lymphoma as a second malignancy in chronic lymphocytic leukaemia. Br J Haematol 2000; 108: 660–661
   PubMed Web of Science ®Google Scholar
• Au W Y, Gascoyne R D, Le N, Viswanatha D S, Klasa R J, Gallagher R, et al. Incidence of second neoplasms in patients with MALT lymphoma: no increase in risk above the background population. Ann Oncol 1999; 10: 317–321
   PubMed Web of Science ®Google Scholar
• Rey J, Coso D, Ramuz O, Xerri L, Sainty D, Giovannini M, et al. Low-grade rectal malt lymphoma occurring in a patient with chronic lymphocytic leukaemia. Br J Haematol 2002; 119: 1137–1138
   PubMed Web of Science ®Google Scholar
• Shimizu K, Hara K, Yatabe Y. Hodgkin's disease following extranodal marginal zone B-cell lymphoma in remission. Int J Hematol 1999; 69: 96–100
   PubMed Web of Science ®Google Scholar
• Zettl A, Rudiger T, Marx A, Muller-Hermelink H K, Ott G. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases. Histopathology 2005; 46: 217–228
   PubMed Web of Science ®Google Scholar
• King L J, Padley S P, Wotherspoon A C, Nicholson A G. Pulmonary MALT lymphoma: imaging findings in 24 cases. Eur Radiol 2000; 10: 1932–1938
   PubMed Web of Science ®Google Scholar
• Lewis E R, Caskey C I, Fishman E K. Lymphoma of the lung: CT findings in 31 patients. AJR Am J Roentgenol 1991; 156: 711–714
   PubMed Web of Science ®Google Scholar
• Alinari L, Castellucci P, Elstrom R, Ambrosini V, Stefoni V, Nanni C, et al. 18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. Leuk Lymphoma 2006; 47: 2096–2101
   PubMed Web of Science ®Google Scholar
• Poletti V, Romagna M, Gasponi A, Baruzzi G, Allen K A. Bronchoalveolar lavage in the diagnosis of low-grade, MALT type, B-cell lymphoma in the lung. Monaldi Arch Chest Dis 1995; 50: 191–194
   PubMedGoogle Scholar
• Hashemi S M, Heitbrink M A, Jiwa M, Boersma W G. A patient with endobronchial BALT lymphoma successfully treated with radiotherapy. Respir Med 2007; 101: 2227–2229
   PubMed Web of Science ®Google Scholar
• Cheung M C, Haynes A E, Stevens A, Meyer R M, Imrie K. Yttrium 90 ibritumomab tiuxetan in lymphoma. Leuk Lymphoma 2006; 47: 967–977
   PubMed Web of Science ®Google Scholar
• Macklis R M. Radioimmunotherapy as a therapeutic option for Non-Hodgkin's lymphoma. Semin Radiat Oncol 2007; 17: 176–183
   PubMed Web of Science ®Google Scholar
• Conconi A, Martinelli G, Thieblemont C, Ferreri A J, Devizzi L, Peccatori F, et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003; 102: 2741–2745
   PubMed Web of Science ®Google Scholar
• Raderer M, Jager G, Brugger S, Puspok A, Fiebiger W, Drach J, et al. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma. Oncology 2003; 65: 306–310
   PubMed Web of Science ®Google Scholar
• Lossos I S, Morgensztern D, Blaya M, Alencar A, Pereira D, Rosenblatt J. Rituximab for treatment of chemoimmunotherapy naive marginal zone lymphoma. Leuk Lymphoma 2007; 48: 1630–1632
   PubMed Web of Science ®Google Scholar
• Hammel P, Haioun C, Chaumette M T, Gaulard P, Divine M, Reyes F, et al. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol 1995; 13: 2524–2529
   PubMed Web of Science ®Google Scholar
• Jager G, Neumeister P, Brezinschek R, Hinterleitner T, Fiebiger W, Penz M, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol 2002; 20: 3872–3877
   PubMed Web of Science ®Google Scholar
• Raderer M, Wohrer S, Bartsch R, Prager G, Drach J, Hejna M, et al. Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma. J Clin Oncol 2005; 23: 8442–8446
   PubMed Web of Science ®Google Scholar
• Wohrer S, Drach J, Hejna M, Scheithauer W, Dirisamer A, Puspok A, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP). Ann Oncol 2003; 14: 1758–1761
   PubMed Web of Science ®Google Scholar
• Zinzani P L, Stefoni V, Musuraca G, Tani M, Alinari L, Gabriele A, et al. Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer 2004; 100: 2190–2194
   PubMed Web of Science ®Google Scholar
• Thieblemont C, Berger F, Dumontet C, Moullet I, Bouafia F, Felman P, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 2000; 95: 802–806
   PubMed Web of Science ®Google Scholar
• Raderer M, Streubel B, Woehrer S, Puespoek A, Jaeger U, Formanek M, et al. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res 2005; 11: 3349–3352
   PubMed Web of Science ®Google Scholar